Antonis Gounaris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Antonis Gounaris has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
C Costalos
Neonatal Intensive Care Unit and Department of Ultrasonography, Regional General Hospital of Piraeus, Greece
1 shared publicationChristos Costalos
1 shared publicationEfi Kolovou
1 shared publicationK Konstandinidi
Neonatal Intensive Care Unit and Department of Ultrasonography, Regional General Hospital of Piraeus, Greece
1 shared publicationL Varchalama
Department of Ultrasonography, Regional General Hospital of Piraeus
1 shared publicationLia Varchalama
1 shared publication
Latest Publications
- 31 October 2004
- Published by Elsevier in The Journal of Pediatrics
- Vol. 145 (4) , 508-510
Gastric emptying in very-low-birth-weight infants treated with nasal continuous positive airway pressure
- 31 October 2004
- Published by Elsevier in The Journal of Pediatrics
- Vol. 145 (4) , 508-510
Gastric emptying in very-low-birth-weight infants treated with nasal continuous positive airway pressure
- Open Access
- 21 June 2004
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 89 (4) , F297-F299
Theophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial: Figure 1
Background: Theophylline treatment causes side effects such as tachycardia, hyperglycaemia, abdominal distension, and vomiting. The latter two are probably the result of delayed gastric evacuation. Objective: To study the effect of theophylline on gastric emptying time in preterm infants. Patients: The subjects were 18 premature neonates with a mean (SD) birth weight of 1302 (240) g and a mean (SD) gestational age of 28.7 (1.9) weeks. Main outcome measures: In each case, gastric emptying was measured on two occasions: once when the newborns were being treated with theophylline and once when they were not. Half of the cases were randomised to receive theophylline before the initial measurement. The opposite was applied for the rest. Gastric emptying was assessed ultrasonically by measuring the change in antral cross sectional area (ACSA) at regular intervals over 120 minutes. Results: The mean (SD) ACSA half time in the newborns receiving theophylline was 52 (19) minutes compared with 37 (16) minutes in those not receiving theophylline. This difference is significant (p < 0.05). Conclusions: Treatment with theophylline seems to delay gastric emptying in very low birthweight neonates, and this must be taken into consideration when this drug is used to treat apnoea of prematurity.
- 21 June 2004
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 89 (4) , F297-F299
Open AccessTheophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial: Figure 1
Background: Theophylline treatment causes side effects such as tachycardia, hyperglycaemia, abdominal distension, and vomiting. The latter two are probably the result of delayed gastric evacuation. Objective: To study the effect of theophylline on gastric emptying time in preterm infants. Patients: The subjects were 18 premature neonates with a mean (SD) birth weight of 1302 (240) g and a mean (SD) gestational age of 28.7 (1.9) weeks. Main outcome measures: In each case, gastric emptying was measured on two occasions: once when the newborns were being treated with theophylline and once when they were not. Half of the cases were randomised to receive theophylline before the initial measurement. The opposite was applied for the rest. Gastric emptying was assessed ultrasonically by measuring the change in antral cross sectional area (ACSA) at regular intervals over 120 minutes. Results: The mean (SD) ACSA half time in the newborns receiving theophylline was 52 (19) minutes compared with 37 (16) minutes in those not receiving theophylline. This difference is significant (p < 0.05). Conclusions: Treatment with theophylline seems to delay gastric emptying in very low birthweight neonates, and this must be taken into consideration when this drug is used to treat apnoea of prematurity.